EMA: While the FDA granted Wegovy an additional indication for CV risk reduction, the EMA did not deem this necessary and only added SELECT data to its label
doi:10.1097/AOG.0000000000004395 Related Articles
Together, they produce a stronger, more sustained GH pulse than either peptide alone without spiking cortisol or prolactin, which can actually disrupt sleep
The modest rating volume means it should be treated as early marketplace feedback rather than strong validation
GLP-1s (like Ozempic and Wegovy) get a lot of media attention for weight loss, but theyre actually extremely effective diabetes medications (or, at least, thats how they first arrived on the medicinal scene)
How is Tesamorelin / Ipamorelin layered with weight loss peptides